| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/26/2002 | US6361972 Compositions and methods for non-targeted activation of endogenous genes |
| 03/26/2002 | US6361970 A polypeptide encoding an isoleucyl trna synthetase; therapy and screening antibiotic compounds |
| 03/26/2002 | US6361968 Extension of a protein-protein interaction surface to inactive the function of a cellular protein |
| 03/26/2002 | US6361967 Axor10, a g-protein coupled receptor |
| 03/26/2002 | US6361946 A bone marrow modulating method in mammals by adminstering a polypeptide that binds to at least one endothelial cell surface receptor to modulates myelopoiesis |
| 03/26/2002 | US6361938 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 03/26/2002 | US6361779 Transferrin receptor genes |
| 03/26/2002 | US6361771 Implantable cell culture device comprising semipermeable membrane permitting diffusion of growth factor therethrough, and arpe-19 cells genetically engineered to produce growth factor disposed within semipermeable membrane |
| 03/26/2002 | US6361770 Introducing ex vivo nucleic acid molecule comprising sequence encoding tap-1 into tumor cell, expressing tap-1 in tumor cell, permitting recognition of tumor by mammal's immune response, introducing tumor cell into mammal |
| 03/26/2002 | CA2180570C Isolated p27 protein and its encoding nucleic acid molecules |
| 03/26/2002 | CA2144514C Morphogen-induced liver regeneration |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022864A1 The method of detecting mutant dspp gene of hereditary opalescent |
| 03/21/2002 | WO2002022839A2 Internal ribosome entry sites (ires) of errantiviruses and uses thereof |
| 03/21/2002 | WO2002022830A2 Transglutaminase gene products |
| 03/21/2002 | WO2002022825A2 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
| 03/21/2002 | WO2002022819A2 Calcium binding proteins |
| 03/21/2002 | WO2002022817A2 Nuclear receptor l66 and methods of use |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022798A2 Modulation of homologous recombination with single stranded dna binding proteins |
| 03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | WO2002022783A2 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | WO2002022663A2 Stress resistant retroviruses |
| 03/21/2002 | WO2002022657A2 Peptide antagonist of multiple chemokine receptors and uses thereof |
| 03/21/2002 | WO2002022642A1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 03/21/2002 | WO2002022641A1 Antisense modulation of caspase 9 expression |
| 03/21/2002 | WO2002022640A1 Antisense modulation of caspase 7 expression |
| 03/21/2002 | WO2002022639A1 Antisense modulation of btak expression |
| 03/21/2002 | WO2002022636A1 Antisense modulation of her-2 expression |
| 03/21/2002 | WO2002022635A1 Antisense modulation of clusterin expression |
| 03/21/2002 | WO2002022631A2 Regulation of human pyroglutamyl peptidase-like enzyme |
| 03/21/2002 | WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | WO2002022177A2 High efficiency cardiac gene transfer |
| 03/21/2002 | WO2002022176A1 Method of modulating neovascularization |
| 03/21/2002 | WO2002022175A2 Method and composition for treating tumors by selective induction of apoptosis |
| 03/21/2002 | WO2002022174A1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 03/21/2002 | WO2002022162A1 Remedies for amyotrophic lateral sclerosis |
| 03/21/2002 | WO2002022161A2 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | WO2002022160A2 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 03/21/2002 | WO2002022151A2 Use of glp-1 and flp-2 peptides for treatment of bone disorders |
| 03/21/2002 | WO2002022149A1 Use of il-6r/il-6 chimera in huntington's disease |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2002000024A8 New strategy for leukemia therapy |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001077376A8 Diagnosis of diseases associated with metastasis |
| 03/21/2002 | WO2001077164A8 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
| 03/21/2002 | WO2001074379A3 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001062942A3 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 03/21/2002 | WO2001062725A3 Methods and compositions for inhibiting angiogenesis |
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001060990A3 Sphingosine kinases |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001042295A3 Clasp-7 transmembrane protein |
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | WO2001029232A3 Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
| 03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
| 03/21/2002 | US20020035737 Cloning pigs using donor nuclei from differentiated cells |
| 03/21/2002 | US20020035735 Reproducing and animal; obtain preferential embryonic cells, culture cells, transfer cells to primate, recover infant |
| 03/21/2002 | US20020035356 Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer |
| 03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
| 03/21/2002 | US20020035083 CRF2 ligands in combination therapy |
| 03/21/2002 | US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism |
| 03/21/2002 | US20020035080 Proliferation potential proteins (P2P), involved in RNA processing; repressing the proliferative potential of a cell with an antisense oligonucleotide that binds to a domain of the open reading frame of P2P cDNA |
| 03/21/2002 | US20020035079 Mutated cyclin G1 protein |
| 03/21/2002 | US20020035078 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity |
| 03/21/2002 | US20020035056 54420, a novel human calcium channel |
| 03/21/2002 | US20020034822 Integrative protein-DNA cochleate formulations and methods for transforming cells |
| 03/21/2002 | US20020034821 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 03/21/2002 | US20020034813 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034738 Human vascular ibp-like growth factor |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034551 Method of making microencapsulated DNA for vaccination and gene therapy |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034505 Genetic enginnering; kits |
| 03/21/2002 | US20020034503 Insertion gene into retrovirus; then into skin cells |
| 03/21/2002 | US20020034502 Retroviral vectors |
| 03/21/2002 | US20020034501 Methods and compositions for promoting angiogenesis using monocytes |
| 03/21/2002 | US20020034498 Polymer-modified viruses |
| 03/21/2002 | US20020034495 Gene therapy |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | DE10043674A1 New antisense oligonucleotides and ribozymes, useful for treating e.g. pain and for diagnosis, are directed against mRNA for vanilloid-family receptors |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422774A1 Remedies for amyotrophic lateral sclerosis |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422175A1 Modulation of homologous recombination with single stranded dna binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |